✦ LIBER ✦
MS42 IMPROVED LIPID REDUCTION AND TARGET ATTAINMENT WITH EZETIMIBE/SIMVASTATIN VERSUS ROSUVASTATIN IN HIGH-RISK PATIENTS FAILING PRIOR STATIN THERAPY: AGE FACTOR
✍ Scribed by Missault, L.; Vaverkova, H.; Farnier, M.; Averna, M.; Viigimaa, M.; Dong, Q.; Shah, A.; Taggart, W.; Brudi, P.
- Book ID
- 118638548
- Publisher
- Elsevier Science
- Year
- 2010
- Tongue
- English
- Weight
- 57 KB
- Volume
- 11
- Category
- Article
- ISSN
- 1567-5688
No coin nor oath required. For personal study only.